Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data analysis. [electronic resource]
- Gynecologic oncology Nov 2016
- 294-301 p. digital
Publication Type: Journal Article
1095-6859
10.1016/j.ygyno.2016.08.317 doi
Age Factors Aged Aged, 80 and over Biomarkers Brachytherapy Chemoradiotherapy Female Humans Middle Aged Prognosis Uterine Cervical Neoplasms--mortality